
Taiho Oncology and Taiho Pharmaceutical have announced that the US Food and Drug Administration (FDA) has approved Lonsurf (trifluridine/tipiracil) as …

Taiho Ventures has invested in California-based Arcus Biosciences alongside GV, Invus, DROIA Oncology Ventures and Stanford University as part of …

Japan-based pharma firm Taiho Oncology has appointed Tim Whitten to the position of senior vice president and chief commercial officer. …
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board

